Clinical Trial Update: Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing the efficacy, safety, and tolerability of BPaMZ in drug-sensitive and drug-resistant pulmonary tuberculosis; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis

Drugs mentioned

• BPaMZ

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-11-08